Evidence map›Paper›PMID 29560281›Full record

ArticleCell death discovery2018

Regulation of transforming growth factor is involved in the efficacy of combined 5-fluorouracil and interferon alpha-2b therapy of advanced hepatocellular carcinoma.

Youhei Okada, Ting Wang, Kazuhiro Kasai, Kazuyuki Suzuki, Yasuhiro Takikawa

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Oncogenic Pathways in Neurodegenerative Diseases.International journal of molecular sciences · 2022
    Review
  5. TGF-β Signaling and Resistance to Cancer Therapy.Frontiers in cell and developmental biology · 2021
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Youhei OkadaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University, Morioka, Iwate Japan.
Ting WangDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University, Morioka, Iwate Japan.
Kazuhiro KasaiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University, Morioka, Iwate Japan.
Kazuyuki SuzukiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University, Morioka, Iwate Japan.
Yasuhiro TakikawaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University, Morioka, Iwate Japan.
Iwate Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transforming growth factor-beta (TGF-β) is critical in cancer cell invasion and metastasis. The effects of a treatment that targets TGF-β using the combination of interferon alpha (IFNα)-2b and 5-fluorouracil (5-FU) are unknown. Here, we show that the serum levels of TGF-β1 prior to the therapy correlate with increased maximum tumor diameter, which is significantly (

Identifiers

PMID29560281
PMCPMC5849890
OpenAlexW2806207928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.